Lakefront Biotherapeutics NV (LKFT)
NASDAQ: LKFT · Real-Time Price · USD
30.27
-0.32 (-1.05%)
At close: Jul 10, 2026, 4:00 PM EDT
30.26
-0.01 (-0.03%)
After-hours: Jul 10, 2026, 4:10 PM EDT
Lakefront Biotherapeutics NV Employees
Lakefront Biotherapeutics NV had 558 employees as of June 30, 2025. The number of employees decreased by 146 or -20.74% since the number was reported on December 31, 2024.
Employees
558
Change
-146
Growth
-20.74%
Revenue / Employee
$2,156,720
Profits / Employee
$1,009,971
Market Cap
1.98B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 558 | -146 | -20.74% |
| Dec 31, 2024 | 704 | -419 | -37.31% |
| Dec 31, 2023 | 1,123 | -215 | -16.07% |
| Dec 31, 2022 | 1,338 | 29 | 2.22% |
| Dec 31, 2021 | 1,309 | -180 | -12.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Intellia Therapeutics | 377 |
| Nuvation Bio | 307 |
| Monte Rosa Therapeutics | 187 |
| Stoke Therapeutics | 170 |
| Aurinia Pharmaceuticals | 128 |
| AnaptysBio | 104 |
| Taysha Gene Therapies | 99 |
LKFT News
- 2 days ago - Lakefront Biotherapeutics resumed with an Equal Weight at Morgan Stanley - TheFly
- 4 days ago - Acquisition of Own Shares - GlobeNewsWire
- 11 days ago - Acquisition of Own Shares - GlobeNewsWire
- 12 days ago - Lakefront Receives Transparency Notification from Madison Avenue Partners - GlobeNewsWire
- 4 weeks ago - Lakefront Biotherapeutics announces EUR 50M share repurchase program - TheFly
- 4 weeks ago - Lakefront Announces Initiation of €50 Million Stock Repurchase Program - GlobeNewsWire
- 4 weeks ago - Lakefront Biotherapeutics appoints Eric Hedrick chief medical officer - TheFly
- 4 weeks ago - Lakefront Appoints Eric Hedrick, MD, as Chief Medical Officer - GlobeNewsWire